Summit Therapeutics Share Discussion Threads

[football] 05/3/2019 08:43

sorry Rocket has set up a fake account looking at the spelling of fooball it as a I on the instead of a l


Rockrts new fake accont

footbalI
Member since: 05 Mar 2019

(look at the i on the end)





my real account

football
Member since: 08 Feb 2001
PREMIUM

[rocket fuel] 05/3/2019 08:10

I fancy the share price will be heading back down thru the red line today, chaps.

[rocket fuel] 05/3/2019 07:44

WOW, footy must have bumped his head when he woke up this morning.. he has seen the light, at last!

great post footy!



football 5 Mar '19 - 07:06 - 1654 of 1657 7.000 0 1

Still no one's been in contact with the company and asking why was misleading the market saying everything is green and positive when on their own website it says are inadequate.

Got to ask yourself again if it's so positive like you keep saying and the rest of them you who is dumping all the shares now not another institution taking a 75% plus loss on their investment just to get out at any price?


expecting this share to crash and waiting for a buying opportunity but you criticise me for saying that the share is falling


Who's the bigger hypocrite me that's pointing out a few negativities and false reporting by the company

waiting for 6-7p

[waterloo01] 05/3/2019 07:43

Filtered. I see you have exactly he same series of posts on other company threads.

[waterloo01] 05/3/2019 07:23

Is this anything to do with Summit?

[rocket fuel] 04/3/2019 16:32

once a blag.. always a blag!

[rocket fuel] 04/3/2019 16:32

watch out on this one.. double top about to break down and trap door about to swing open..

..back down to 20p

[gooosed] 02/3/2019 15:05

waterloo01 - Thanks, Summit appear to be well funded/backed & in a position to develop new targets. Will be watching quietly from the sidelines.

[waterloo01] 02/3/2019 14:22

Probably selection of next targets out of Discova platform. Eskape pathogens were mentioned in a recent interview.

Apart from that, possible further grants or fast track for Gonorrhoea into safety trial?

ESKAPE is an acronym encompassing the names of six bacterial pathogens commonly associated with antimicrobial resistance:[1] ESKAPE is an acronym for their names and a reference to their ability to escape the effects of commonly used antibiotics through evolutionarily developed mechanisms, and also because it is a acronym for their names.[2]

The six species are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter.

[gooosed] 02/3/2019 14:02

New to SUMM with first buys last month . . . thoughts on next value inflection points would be welcome.

[kirk 6] 01/3/2019 20:42

Booming next leg to 45p or $3 could be on the cards

[kirk 6] 01/3/2019 18:34

Moving up in US again